
Boundless Life What Happens During A Psychedelic Journey: Dr. Matthew Johnson On Psychedelic Treatment Room, The State Of Psychedelic Research & Future of Psychedelic Therapy.
Jun 18, 2020
Dr. Matthew Johnson, a leading researcher on psychedelics from Johns Hopkins, dives into the transformative potential of psychedelic therapy. He discusses the urgent need for effective treatments for PTSD, particularly through MDMA-assisted psychotherapy. The conversation also touches on the challenges of fundraising for vital psychedelic research and the promising role of psilocybin in mental health. With a blend of humor and insight, Johnson addresses misconceptions and outlines the future landscape of psychedelic treatments and their therapeutic implications.
AI Snips
Chapters
Transcript
Episode notes
Benefits for Healthy Individuals
- Psychedelics can benefit "healthy normals" seeking self-optimization beyond addressing specific disorders.
- Studies show positive changes in well-being and improved outcomes from practices like meditation.
Microdosing Research
- Microdosing research is limited, with current studies showing minimal benefits and slight impairment.
- Anecdotal reports of enhanced performance and flow states need rigorous testing to verify effects beyond placebo.
Psilocybin for Tobacco Addiction
- Psilocybin shows promise for treating tobacco addiction, with an 80% success rate in a pilot study.
- This surpasses nicotine replacement therapies, showing potential as a more effective treatment.

